194 related articles for article (PubMed ID: 27760327)
1. Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein.
Gao S; Gao Y; He HH; Han D; Han W; Avery A; Macoska JA; Liu X; Chen S; Ma F; Chen S; Balk SP; Cai C
Cell Rep; 2016 Oct; 17(4):966-976. PubMed ID: 27760327
[TBL] [Abstract][Full Text] [Related]
2. Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer.
Han W; Liu M; Han D; Toure AA; Li M; Besschetnova A; Wang Z; Patalano S; Macoska JA; Lam HM; Corey E; He HH; Gao S; Balk SP; Cai C
Mol Ther; 2022 Apr; 30(4):1628-1644. PubMed ID: 35121110
[TBL] [Abstract][Full Text] [Related]
3. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
Bohrer LR; Chen S; Hallstrom TC; Huang H
Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
[TBL] [Abstract][Full Text] [Related]
4. ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer.
Han D; Chen S; Han W; Gao S; Owiredu JN; Li M; Balk SP; He HH; Cai C
Cancer Res; 2019 Oct; 79(20):5260-5271. PubMed ID: 31444154
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.
Yuan X; Li T; Wang H; Zhang T; Barua M; Borgesi RA; Bubley GJ; Lu ML; Balk SP
Am J Pathol; 2006 Aug; 169(2):682-96. PubMed ID: 16877366
[TBL] [Abstract][Full Text] [Related]
7. AR, the cell cycle, and prostate cancer.
Balk SP; Knudsen KE
Nucl Recept Signal; 2008 Feb; 6():e001. PubMed ID: 18301781
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
10. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor suppressor dysregulation in prostate cancer progression.
Dean JL; Knudsen KE
Curr Drug Targets; 2013 Apr; 14(4):460-71. PubMed ID: 23410128
[TBL] [Abstract][Full Text] [Related]
14. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
[TBL] [Abstract][Full Text] [Related]
15. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
16. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
17. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
18. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.
Yeh S; Miyamoto H; Nishimura K; Kang H; Ludlow J; Hsiao P; Wang C; Su C; Chang C
Biochem Biophys Res Commun; 1998 Jul; 248(2):361-7. PubMed ID: 9675141
[TBL] [Abstract][Full Text] [Related]
20. Androgen stimulated cellular proliferation in the human prostate cancer cell line LNCaP is associated with reduced retinoblastoma protein expression.
Taneja SS; Ha S; Garabedian MJ
J Cell Biochem; 2001; 84(1):188-99. PubMed ID: 11746527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
